The Gross Margin of Sichuan Goldstone Asia Pharmaceutical Inc (300434.SZ) is 58.07%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 58.07% |
| 2024-12-31 | 57.08% |
| 2023-12-31 | 61.37% |
| 2022-12-31 | 61.31% |
| 2021-12-31 | 56.38% |
| 2020-12-31 | 53.71% |
| 2019-12-31 | 64.39% |
| 2018-12-31 | 65.91% |
| 2017-12-31 | 63.93% |
| 2016-12-31 | 34.54% |